Key Statistics: FMCX

FMC EXCELSIOR FOCUS EQUITY ETF

25.05up0.2578 (1.0398%)

 as of 4:10:00pm ET 08/12/2022

Basic Facts

ETP Type ETF Sponsor First Manhattan Company
Legal Structure Open Ended Investment Company Inception Date 04/22/2022
Schedule K-1 -- Options No
Leveraged No Manager Himayani Puri
Inverse No

Manager

Himayani Puri

Tenure: 3 months

Himayani Puri is a Senior Managing Director, the Director of Research, and a member of the Management Committee of First Manhattan Co. Ms. Puri also acts as the portfolio manager for a private fund managed by the Adviser that has an investment objective, policies and strategies similar to those of the Fund. She has over 25 years of experience as a value-oriented investor across multiple industries and cycles. Ms. Puri was previously a Partner and Director of Research at Cerrano Capital, a concentrated, equity-focused long/short investment firm founded in 2016. Previously, she was a founding Partner of Realm Partners, which was the successor entity to Lehman Brothers’ Principal Investing Group. At Realm, which applied value investing principles across equities and distressed credit, her primary investment focus was on multi-year holdings in companies undergoing structural change. She co-founded Realm in January 2009 and served as a Portfolio Manager and Director of Research until December 2015. Prior to the formation of Realm, Ms. Puri was a Managing Director in the Principal Investing Group at Lehman Brothers, the proprietary investing arm of the firm. Prior to joining the Principal Investing Group in 1998, she spent two years as an Analyst in the Private Equity division at Lehman Brothers, where she worked on evaluating and structuring private investments and buyouts. Ms. Puri is a graduate of the Management & Technology dual-degree Program at The University of Pennsylvania, where she earned a BS in Economics—with concentrations in Finance and Management—from The Wharton School and a BAS in Systems Engineering from the School of Engineering and Applied Science.

Portfolio Fundamentals

Valuation Info FMCX Asset Class Median Percentile in Asset Class
Tracking Error -- 9.92
--
Annual Turnover Ratio -- 28.00%
--
Efficiency -- -1.02
--
Tax Cost Ratio -- 0.55%
--
Equity: Price/Trailing Earnings -- 15.22
--
Equity: Price/Book -- 2.42
--
Equity: Price/Sales -- 1.67
--
Equity: Price/Cash Flow -- 11.56
--
30-day SEC Yield
AS OF --
-- 1.52%
--
Dividend Yield (Annualized) 0.04% n/a n/a
Net Expense Ratio 0.70% 0.57%
33rd
Gross Expense Ratio 0.70% 0.59%
37th
Equity: Historical Earnings Growth % -- +17.66%
--
Equity: Sales Growth % -- +8.06%
--
Equity: Cash Flow Growth % -- +13.09%
--
Equity: Book-Value Growth % -- +8.22%
--
Net Assets $74.3M $97.0M
47th

Trading Statistics

Valuation Info FMCX Asset Class Median Percentile in Asset Class
Median Bid/Ask Spread (30 Day) -- 0.17%
--
Premium/Discount (1 Month Rolling Average) -0.16% 0.00%
41st
Premium/Discount (1 Year Average) -0.02% 0.01%
38th
Volume 102.0 10.8K
9th
Volume (Today/Avg 10 Day) 1.4 0.7
84th
Volume (10 Day Average) 74.4 15.2K
3rd
Volume (30 Day Average) 311.1 17.8K
6th
Volume (90 Day Average) -- 22.6K
--
Volume (10 Day Avg/90 Day Avg) -- 0.7
--
Shares Outstanding 3.1M 2.9M
52nd
Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. The sale of ETFs is subject to an activity assessment fee (from $0.01 to $0.03 per $1,000 of principal). ETFs are subject to market fluctuation and the risks of their underlying investments. ETFs are subject to management fees and other expenses. Unlike mutual funds, ETF shares are bought and sold at market price, which may be higher or lower than their NAV, and are not individually redeemed from the fund.

The performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. Click on the "Performance & Risk" link to view quarter-end performance.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF’s prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock Inc., and its affiliates.

Fidelity receives compensation from the funds advisor or its affiliates in connection with a licensing agreement to utilize Fidelity’s active ETF methodology which may create incentives for FBS to encourage the purchase of certain ETFs.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.